With the analysis among 332 patents, we discovered top 167 key players by total patent application. GlaxoSmithKline Biologicals SA, SL VaxiGen, Inc., Zoetis Services LLC are dominant in this area. They take 15.96% of the total patent filing.
New Jersey, United States
Patent: 13
Pennsylvania, United States
Patent: 9
Jiangsu Sheng, China
Patent: 9
Henan Sheng, China
Patent: 9
Noord-Brabant, Netherlands
Patent: 8
Zuid-Holland, Netherlands
Patent: 7
With the analysis among 4 patents, we discovered top 3 start-ups by total patent application.
California, United States
Patent: 1
With the analysis among related 307 patents applied in the last 5 years. We discover 178 most active companies in this area. The fast-growing GlaxoSmithKline Biologicals SA, SL VaxiGen, Inc., Yidao Biotechnology (Suzhou) Co. Ltd. take 11.07% of patent filing during this period.
Jiangsu Sheng, China
Patent: 9
Henan Sheng, China
Patent: 9
Noord-Brabant, Netherlands
Patent: 7
Jiangsu Sheng, China
Patent: 6
Pennsylvania, United States
Patent: 5
With the analysis among related 307 patents in last 5 years, we discover 155 new entrants. Yidao Biotechnology (Suzhou) Co. Ltd., Luohe Sunmit Biotechnology Co., Ltd., Yangzhou University are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 9
Henan Sheng, China
Patent: 9
Jiangsu Sheng, China
Patent: 6
Bến Tre, Vietnam
Patent: 4
Yunnan Sheng, China
Patent: 3
undefined undefined
Patent: 3
Beijing Shi, China
Patent: 3
Sichuan Chengyu Biological Products Co., Ltd.
Sichuan Sheng, China
Patent: 3
With the analysis among 201 patents, we discovered top 65 universities and scientific research institutions by total patent application. Yangzhou University, Fudan University, Tsinghua University are dominant in this area. They take 18.91% of the total patent filing.
Jiangsu Sheng, China
Patent: 6
Shanghai Shi, China
Patent: 3
Beijing Shi, China
Patent: 3
Washington, United States
Patent: 2
Texas, United States
Patent: 2
Manitoba, Canada
Patent: 2
Beijing Shi, China
Patent: 2
Jilin Sheng, China
Patent: 2